Uniqure N.V.. (5/12/16). "Press Release: Uniqure to Present at Upcoming Investor Conferences in New York City". Amsterdam.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Uniqure N.V. (Nasdaq: QURE)
	Group	Uniqure (Group)
	Organisation 2	MacDougall Biomedical Communications Inc. (MBI), European Office
	Group	MacDougall Biomedical Communications Inc. (MBI)
	Product	UBS Global Healthcare Conference 2016 New York
	Product 2	Jefferies 2016 Global Healthcare Conference New York
	Index term	Uniqure–UBS: investor conference, 201605 supply service Uniqure presents at UBS Global Healthcare Conference NY
	Index term 2	Uniqure–MacDougall Biomedical Communications: public relations, 201412 service existent
	Person	Soland, Daniel (Dan) (Uniqure 201512–201609 CEO before ViroPharma + Chiron Vaccines + Epigenesis RESIGNED 9/16)
	Person 2	Kapusta, Matthew (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew Orthopaedics)

uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that its management will be presenting at the below listed investor conferences in May and June, 2016.

Piper Jaffray GenomeRx Symposium

Venue: The InterContinental New York Barclay Hotel, New York City
Title: Getting to the Heart (& Muscle) of the Gene Therapy Matter
Presenter: Christian Meyer, Chief Medical Officer
Date and Time: May 17, 2016: 10.40 AM EDT

2016 UBS Global Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City
Presenter: Daniel Soland, Chief Executive Officer
Date and Time: May 24, 2016: 08.00 AM EDT
Webcast: A webcast of the presentation will be available through the details listed below

Jefferies 2016 Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City
Presenter: Matt Kapusta, Chief Financial Officer
Date and Time: June 10, 2016: 11.00 AM EDT

The webcast, including a slide presentation at the 2016 UBS Global Healthcare Conference, can be accessed through the following link: https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=47_SI2EH82 or by accessing the link displayed in the “Events” section on the “Media” page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

uniQure:
Eva Mulder
Direct : +31 20 240 6103
Main: +31 20 240 6000
e.mulder@uniQure.com

Media inquiries:
Gretchen Schweitzer or Stephanie May
MacDougall Biomedical Communications
Direct: +49 172 861 8540 or +49 175 5711562
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com

Record changed: 2017-07-02